Grace Truong

ID: 1b83d7cb-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Recent PTAB Developments for Regeneron’s Aflibercept Formulation Patent

Big Molecule Watch · June 20, 2025

Updates on Aflibercept Biosimilar Approvals and BPCIA Litigation

Big Molecule Watch · June 8, 2024

Federal Circuit Dismisses Appeals in Regeneron v. Mylan (Aflibercept) BPCIA Litigation

Big Molecule Watch · April 22, 2024

DOJ Files False Claims Act Complaint Against Regeneron, Alleging Fraudulent Eylea Drug Pricing

Big Molecule Watch · April 22, 2024

Post-Trial Updates on Regeneron v. Mylan (Aflibercept) BPCIA Litigation

Big Molecule Watch · March 1, 2024